Kim KS - Search Results

1

Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.

Kim M, Lee JS, Kim W, Lee JH, Jun BH, Kim KS, Kim DE. Kim M, et al. Among authors: kim de, kim w, kim ks. J Control Release. 2022 Aug;348:893-910. doi: 10.1016/j.jconrel.2022.06.039. Epub 2022 Jun 29. J Control Release. 2022. PMID: 35760233

2

Sendai F/HN viroplexes for efficient transfection of leukemic T cells.

Kim JS, Lee YK, Jeong HY, Kang SJ, Kim MW, Ryu SH, Kim HS, Kim KS, Kim DE, Park YS. Kim JS, et al. Among authors: kim de, kim ks, kim mw, kim hs. Yonsei Med J. 2013 Sep;54(5):1149-57. doi: 10.3349/ymj.2013.54.5.1149. Yonsei Med J. 2013. PMID: 23918564 Free PMC article.

3

RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.

Baek SE, Lee KH, Park YS, Oh DK, Oh S, Kim KS, Kim DE. Baek SE, et al. Among authors: kim de, kim ks. J Control Release. 2014 Dec 28;196:234-42. doi: 10.1016/j.jconrel.2014.10.018. Epub 2014 Oct 24. J Control Release. 2014. PMID: 25450401

4

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.

Oh HR, Jo HY, Park JS, Kim DE, Cho JY, Kim PH, Kim KS. Oh HR, et al. Among authors: kim de, kim ph, kim ks. Nanomaterials (Basel). 2016 Jul 30;6(8):141. doi: 10.3390/nano6080141. Nanomaterials (Basel). 2016. PMID: 28335269 Free PMC article.

5

Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.

Kim M, Kim DM, Kim KS, Jung W, Kim DE. Kim M, et al. Among authors: kim de, kim ks, kim dm. Molecules. 2018 Apr 4;23(4):830. doi: 10.3390/molecules23040830. Molecules. 2018. PMID: 29617327 Free PMC article. Review.

6

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles.

Kim JS, Kim MW, Kang SJ, Jeong HY, Park SI, Lee YK, Kim HS, Kim KS, Park YS. Kim JS, et al. Among authors: kim ks, kim mw, kim hs. Int J Nanomedicine. 2018 Aug 27;13:4817-4830. doi: 10.2147/IJN.S161932. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30214190 Free PMC article.

7

Anti-MUC1/CD44 Dual-Aptamer-Conjugated Liposomes for Cotargeting Breast Cancer Cells and Cancer Stem Cells.

Kim DM, Kim M, Park HB, Kim KS, Kim DE. Kim DM, et al. Among authors: kim de, kim m, kim ks. ACS Appl Bio Mater. 2019 Oct 21;2(10):4622-4633. doi: 10.1021/acsabm.9b00705. Epub 2019 Sep 11. ACS Appl Bio Mater. 2019. PMID: 35021421

8

Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells.

Koh EY, Kim KS, Park HB, Kim JS, Kim PH. Koh EY, et al. Among authors: kim ks, kim ph, kim js. Int J Mol Sci. 2022 Dec 30;24(1):685. doi: 10.3390/ijms24010685. Int J Mol Sci. 2022. PMID: 36614128 Free PMC article.

9

Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening.

Miller Z, Kim KS, Lee DM, Kasam V, Baek SE, Lee KH, Zhang YY, Ao L, Carmony K, Lee NR, Zhou S, Zhao Q, Jang Y, Jeong HY, Zhan CG, Lee W, Kim DE, Kim KB. Miller Z, et al. Among authors: kim de, kim kb, kim ks. J Med Chem. 2015 Feb 26;58(4):2036-41. doi: 10.1021/jm501344n. Epub 2015 Feb 17. J Med Chem. 2015. PMID: 25658656

10

Sendai viroplexes for epidermal growth factor receptor-directed delivery of interleukin-12 and salmosin genes to cancer cells.

Kim JS, Kim MW, Jeong HY, Kang SJ, Park SI, Lee YK, Kim HS, Kim KS, Park YS. Kim JS, et al. Among authors: kim ks, kim mw, kim hs. J Gene Med. 2016 Jul;18(7):112-23. doi: 10.1002/jgm.2884. J Gene Med. 2016. PMID: 27191929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,374 results

Search Page